Serum lipids and arterial plaque load are altered independently with high-dose progesterone in hypercholesterolemic male rabbits

Cardiovascular Pathology

Volumn 9, Issue 6, 2000, Pages 317-322

  Houser, Stuart L ^a   Aretz, H Thomas ^a   Quist, William C ^b   Chang, YuChiao ^a,c   Schreiber, Alan D ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRIOL; HALOPERIDOL; HYDROXYPROGESTERONE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HISTOLOGY; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MALE; MICROSCOPY; MORPHOMETRICS; MULTIVARIATE ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; TISSUE SECTION; TRIACYLGLYCEROL BLOOD LEVEL;

17-ALPHA-HYDROXYPROGESTERONE; ANIMALS; AORTA; CHOLESTEROL; CHOLESTEROL, DIETARY; CORONARY ARTERIOSCLEROSIS; DIET, ATHEROGENIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRIOL; HALOPERIDOL; HYPERCHOLESTEROLEMIA; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; RABBITS; TRIGLYCERIDES;

EID: 0034546856     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1054-8807(00)00051-X     Document Type: Article

References (49)

1. Coronary artery disease in women
2. Age,sex and hypertension in myocardial infarction due to coronary occlusion
3. Menopause and the risk of coronary heart disease in women
4. Menopause and heart disease; a review
5. Cardiovascular health and disease in women
6. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The postmeno-pausal estrogen/progestin interventions (PEPI) trial
7. The epidemiology of coronary heart disease and estrogen replacement therapy in post-menopausal women
8. Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxy-progesterone derivatives
9. Effects of different progestogens on lipoproteins during postmenaopausal replacement therapy
10. Post-menopausal estrogen and progestin use and the risk of cardiovascular disease
11. Estrogen modulates responses of atherosclerotic coronary arteries
12. Endothelium independent relaxation of human coronary arteries by 17-oestradiol in vitro
13. Oestrogens, arterial status, and postmenopausal women
14. Estrogen and inhibition of oxidation of low-density lipoprotein in postmenopausal women
15. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease
16. Cardiovascular protection by oestrogen-a calcium antagonist effect?
17. 1a by uterine arteries from postmenopausal women
18. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause
19. Premature coronary disease associated with a disruptive mutation in the estrogen receptor gene in a man
20. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariec-tomized monkeys. Lack of an effect of added progester-one
21. Norethindrone acetate enhances the antiatherogenic effect of 17-estradiol. A secondary prevention study of aortic atherosclerosis in ovariectomized cholesterol-fed rabbits
22. The inhibition of coronary atherosclerosis by estrogens in cholesterol-fed chicks
23. The inhibition of coronary atheromatosis in cholesterol-fed chicks receiving estrogens
24. Estrogen inhibits the response-to-injury in a mouse carotid artery
25. Exogenous estrogens attenuate dietary hyper-cholesterolemia and atherosclerosis in the rabbit
26. Effects of estradiol and progesterone the increased synthesis of collagen in atherosclerotic rabbit aortas
27. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits
28. Different effects of estrogen and progesterone on experimental atherosclerosis in female versus male rabbits
29. Gender gap in aortic cholesterol accumulation in cholesterol-clamped rabbits
30. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys
31. Effects of estrogen and progesterone on plasma lipoproteins and experimental atherosclerosis in the baboon (Papio sp.)
32. High-dose synthetic progestogens inhibit foam and smooth muscle cell proliferation and athero-sclerotic plaque formation in aortas of rabbits fed a hypercholesterolemic diet
33. Cholesterol-fed and casein-fed rabbit models of atherosclerosis
34. The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and atherosclerotic lesion formation
35. Oestrogen-induced changes in lipoprotein metabolism; role in prevention of atherosclerosis in the cholesterol-fed rabbit
36. Morphometric analysis of the composition of coronary arterial plaques in isolated unstable angina with pain at rest
37. Effect of 17 beta estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits
38. Progestogens do not affect aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits
39. Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm
40. Estrogens, progestins, and coronary artery reactivity
41. Local and systemic estradiol-17 beta; Effects on uterine and systemic vasodilatation
42. Estrogen receptors and effects of estrogen on membrane electrical properties of coronary vascular smooth muscle
43. Estrogen and the blood vessel wall
44. Effect of endogenous and synthetic sex steroids on the clearance of antibody-coated cells
45. A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein
46. Treatment with progesterone analogues decreases macrophage Fcγ receptors expression
47. Inhibition of Fcγ receptor immune clearance by DOPA antagonists
48. Progesterone inhibits arterial smooth muscle cell proliferation
49. Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity